Treatment patterns of individualized real-life tapering approaches based on shared decision-making in rheumatoid arthritis.

ABSTRACT:

Objective

To provide real-world evidence on patient-individual tapering patterns of disease-modifying antirheumatic drugs (DMARDs) in rheumatoid arthritis (RA) patients in daily clinical practice.

Methods

Data obtained through a controlled prospective cohort study in Germany conducted from July 2018 to March 2021 were analyzed. Participants consist of RA patients in sustained remission who were eligible for DMARD tapering at enrolment. Data from RA patients who experienced tapering of DMARDs at least once during the observational period (n = 200) were used. Descriptive analyses of medical outcomes at baseline and at time of first tapering, time to first tapering, tapering patterns by substance group, and tapering intensity were documented.

Results

We did not observe m

SUBMITTER: Birkner B 

PROVIDER: S-EPMC10901995 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature